VSR Financial Services’s iShares Biotechnology ETF IBB Stock Holding History

VSR Financial Services’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-19,530	Closed	-$2.2M	–	592
2015 Q4	$2.2M	Buy	19,530 +3,582	+22%	+$389K	0.23%	106
2015 Q3	$1.61M	Sell	15,948 -1,113	-7%	-$133K	0.18%	137
2015 Q2	$2.1M	Sell	17,061 -789	-4%	-$94.5K	0.22%	120
2015 Q1	$2.04M	Sell	17,850 -69	-0.4%	-$7.61K	0.22%	117
2014 Q4	$1.81M	Sell	17,919 -90	-0.5%	-$8.75K	0.2%	123
2014 Q3	$1.64M	Sell	18,009 -69	-0.4%	-$6.05K	0.2%	127
2014 Q2	$1.55M	Sell	18,078 -15,462	-46%	-$1.22M	0.19%	124
2014 Q1	$2.64M	Buy	33,540 +4,533	+16%	+$378K	0.37%	69
2013 Q4	$2.19M	Sell	29,007 -144	-0.5%	-$10.2K	0.34%	68
2013 Q3	$2.04M	Buy	29,151 +2,781	+11%	+$182K	0.35%	65
2013 Q2	$1.53M	Buy	+26,370	New	+$1.52M	0.3%	78

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

VSR Financial Services's IBB Position: Q1 2016 in Review

VSR Financial Services sold out of iShares Biotechnology ETF (IBB) in Q1 2016, closing a stake of 19,530 shares — an estimated $2.2M sold.

VSR Financial Services first reported a position in IBB in Q2 2013 and held it in 11 quarters. The position peaked at $2.64M in Q1 2014. 415 funds tracked by Wall St. Rank hold IBB as of Q1 2016.

VSR Financial Services reported no remaining iShares Biotechnology ETF position as of Q1 2016 after selling out during the quarter.
VSR Financial Services sold 19,530 iShares Biotechnology ETF shares in Q1 2016, an estimated $2.2M.
VSR Financial Services first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 11 quarters.
VSR Financial Services's iShares Biotechnology ETF position peaked at $2.64M in Q1 2014.
415 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2016.

Based on VSR Financial Services's 13F filing for Q1 2016, filed 5 May 2016.